{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:14:54Z","timestamp":1761185694483,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/2July-2019\/PG-Thesis-HRG"],"award-info":[{"award-number":["3\/2July-2019\/PG-Thesis-HRG"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.parkreldis.2022.10.017","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T13:01:36Z","timestamp":1666702896000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Zonisamide add-on in tremor-dominant Parkinson's disease- A randomized controlled clinical trial"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4452-9144","authenticated-orcid":false,"given":"Kanchana Soman","family":"Pillai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achal Kumar","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4987-7252","authenticated-orcid":false,"given":"Roopa","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-7398","authenticated-orcid":false,"given":"Divya M.","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunmozhimaran","family":"Elavarasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MV Padma","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7217-8882","authenticated-orcid":false,"given":"Mamta Bhushan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.Y.","family":"Vishnu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9673-2473","authenticated-orcid":false,"given":"Kameshwar","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awadh Kishor","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.parkreldis.2022.10.017_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00002512-200016040-00003","article-title":"Tremor-predominant Parkinson's disease. Approaches to treatment","volume":"16","author":"Marjama-Lyons","year":"2000","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.parkreldis.2022.10.017_bib2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mds.870130608","article-title":"Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation","volume":"13","author":"Krack","year":"1998","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"1","key":"10.1016\/j.parkreldis.2022.10.017_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1212\/WNL.49.1.249","article-title":"High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease","volume":"49","author":"Pahwa","year":"1997","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.parkreldis.2022.10.017_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0168-0102(01)00298-X","article-title":"Zonisamide has beneficial effects on Parkinson's disease patients","volume":"41","author":"Murata","year":"2001","journal-title":"Neurosci. Res."},{"issue":"1","key":"10.1016\/j.parkreldis.2022.10.017_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/01.wnl.0000250236.75053.16","article-title":"Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study","volume":"68","author":"Murata","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.parkreldis.2022.10.017_bib6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/mds.26286","article-title":"Zonisamide improves wearing-off in Parkinson's disease: a randomized, double-blind study","volume":"30","author":"Murata","year":"2015","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"4","key":"10.1016\/j.parkreldis.2022.10.017_bib7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.pbb.2010.11.014","article-title":"Effects of T-type calcium channel blockers on a parkinsonian tremor model in rats","volume":"97","author":"Miwa","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.parkreldis.2022.10.017_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mds.21282","article-title":"A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor","volume":"22","author":"Zesiewicz","year":"2007","journal-title":"Mov. Disord. Off J. Mov. Disord. Soc."},{"issue":"6","key":"10.1016\/j.parkreldis.2022.10.017_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/WNF.0b013e318074dd4f","article-title":"Zonisamide for essential tremor","volume":"30","author":"Ondo","year":"2007","journal-title":"Clin. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.parkreldis.2022.10.017_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.22418","article-title":"Zonisamide for essential tremor: an evaluator-blinded study","volume":"24","author":"Handforth","year":"2009","journal-title":"Mov. Disord. Off J. Mov. Disord. Soc."},{"year":"2016","series-title":"UK Parkinson's Disease Society Brain Bank Diagnostic Criteria","author":"Clarke","key":"10.1016\/j.parkreldis.2022.10.017_bib11"},{"issue":"3","key":"10.1016\/j.parkreldis.2022.10.017_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/WNL.0b013e3181ae7af1","article-title":"Course in Parkinson disease subtypes: a 39-year clinicopathologic study","volume":"73","author":"Rajput","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2022.10.017_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.parkreldis.2012.10.008","article-title":"Potential reliability and validity of a modified version of the Unified Parkinson's Disease Rating Scale that could be administered remotely","volume":"19","author":"Abdolahi","year":"2013","journal-title":"Park. Relat. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2022.10.017_bib14","first-page":"685","article-title":"[Effect of zonisamide on resting tremor resistant to antiparkinsonian medication]","volume":"55","author":"Nakanishi","year":"2003","journal-title":"No Shinkei"},{"issue":"7","key":"10.1016\/j.parkreldis.2022.10.017_bib15","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.parkreldis.2012.04.007","article-title":"Actigraphic study of tremor before and after treatment with zonisamide in patients with Parkinson's disease","volume":"18","author":"Mochio","year":"2012","journal-title":"Park. Relat. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2022.10.017_bib16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","article-title":"Gender differences in Parkinson's disease","volume":"78","author":"Haaxma","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.parkreldis.2022.10.017_bib17","first-page":"47","article-title":"Gender differences in determinants and consequences of health and illness","volume":"25","author":"Vlassoff","year":"2007","journal-title":"J. Health Popul. Nutr."},{"issue":"24","key":"10.1016\/j.parkreldis.2022.10.017_bib18","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson's disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.parkreldis.2022.10.017_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1756285609338501","article-title":"A review of the use of zonisamide in Parkinson's disease","volume":"2","author":"Bermejo","year":"2009","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2022.10.017_bib20","first-page":"4123","article-title":"Zonisamide in Parkinson's disease: a current update","volume":"42","author":"Goel","year":"2021","journal-title":"Neurol. Sci. Off. J Ital Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.parkreldis.2022.10.017_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.574652","article-title":"Zonisamide for the treatment of Parkinson disease: a current update","volume":"14","author":"Li","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.parkreldis.2022.10.017_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0920-1211(95)00078-X","article-title":"Effects of zonisamide on dopaminergic system","volume":"22","author":"Okada","year":"1995","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.parkreldis.2022.10.017_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00702-004-0107-1","article-title":"Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson\u2019s activity","volume":"111","author":"Gluck","year":"2004","journal-title":"J. Neural. Transm."},{"issue":"10","key":"10.1016\/j.parkreldis.2022.10.017_bib24","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","article-title":"Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group","volume":"40","author":"Jankovic","year":"1990","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2022.10.017_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2013.582","article-title":"Differences in brain activation between tremor- and nontremor-dominant Parkinson disease","volume":"70","author":"Prodoehl","year":"2013","journal-title":"JAMA Neurol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022003443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022003443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:25:54Z","timestamp":1761179154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802022003443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":25,"alternative-id":["S1353802022003443"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.10.017","relation":{},"ISSN":["1353-8020"],"issn-type":[{"type":"print","value":"1353-8020"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zonisamide add-on in tremor-dominant Parkinson's disease- A randomized controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}